COMMUNIQUÉS West-GlobeNewswire

IBA SA : NOTIFICATION DE TRANSPARENCE

11/07/2017 - 18:00

IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 10 juillet 2017, 17h40 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]

IBA SA : TRANSPARENCY NOTIFICATION

11/07/2017 - 18:00

IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, July 10, 2017, 5.40 p.m. - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]

Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation

11/07/2017 - 16:00

DUBLIN - July 11, 2017 - Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the safety and effectiveness of performing pulmonary vein isolation (PVI [...]

MPI - Last day of trading in paid subscription shares

11/07/2017 - 15:21

Hoersholm, Denmark, July 11 th 2017 - Medical Prognosis Institute A/S ("MPI") completed a rights issue of shares in June 2017 where the public also could subscribe for shares. Through the rights issue 694,715 shares [...]

Novo Nordisk A/S - Share repurchase programme

11/07/2017 - 14:37

Bagsværd, Denmark, 11 July 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Nutrition International : Nutrition International and UNFPA partner to improve women and adolescent girls' health

11/07/2017 - 14:00

LONDON, UK--(Marketwired - July 11, 2017) - Nutrition International and UNFPA, the United Nations Populations Fund , announced today at the Family Planning Summit 2020 in London, a partnership to provide services [...]

Bavarian Nordic A/S - Articles of Association

11/07/2017 - 13:54

Updated Articles of Association for Bavarian Nordic A/S BavarianNordicArticlesofAssociation This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The [...]

uniQure Presents New Clinical Data in Hemophilia B Patients Demonstrating Therapeutic Efficacy of AAV5 Gene Therapy in the Presence of Pre-Existing Neutralizing Antibodies

11/07/2017 - 12:30

-- Findings Further Support Expanding the Eligibility of AAV5 Gene Therapies to Nearly All Patients with Hemophilia B -- LEXINGTON, Mass. and AMSTERDAM, the Netherlands, July 11, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. ( [...]

Össur hf: Q2 2017 Results - Conference call Wednesday 26 July

11/07/2017 - 12:09

Announcement from Össur hf. no: 49/2017 Conference call on Wednesday 26 July at 9:00 CET / 7:00 GMT / 3:00 EDT After market closing on Tuesday 25 July, Össur will publish its financial results for Q2 2017. On Wednesday [...]

Vistin Pharma ASA : Vistin Pharma announces the sale of its Opioids and CMO business

11/07/2017 - 12:03

Oslo, Norway, 11 July 2017 Norwegian pharmaceutical company Vistin Pharma ASA ("Vistin Pharma" or "Company") announced today that the Company has entered a Sales and Purchase agreement with TPI Enterprises Limited ("TPE [...]

Labiaplasty Is the World's Fastest Growing Cosmetic Surgery Procedure, International Study Reports

11/07/2017 - 10:00

An International Study Conducted by the International Society of Aesthetic Plastic Surgery Reveals Significant Growth in Labiaplasty as More Women Choose to Change the Appearance of Their Genital Area NEW YORK, July 11 [...]

NEOVACS : Le Comité Indépendant de Surveillance des Données et de la Tolérance confirme le bon déroulement de l'essai clinique de phase IIb dans le lupus

11/07/2017 - 07:30

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE Le Comité Indépendant de Surveillance des Données et de la Tolérance (iDSMB) confirme le bon déroulement de l'essai clinique de phase IIb dans le lupus avec l'IFNalpha [...]

Neovacs Announces Positive IDSMB Review for Phase IIb Clinical Trial of IFNalpha Kinoid in Lupus

11/07/2017 - 07:30

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE Neovacs Announces Positive IDSMB Review for Phase IIb Clinical Trial of IFNalpha Kinoid in Lupus Third positive data review by IDSMB follows completion of patient [...]

Sanofi to acquire Protein Sciences

11/07/2017 - 07:00

Sanofi to acquire Protein Sciences - Acquisition adds recombinant-based influenza vaccine to Sanofi Pasteur's portfolio - Paris, France - July 11, 2017 - Sanofi announced today it will acquire Protein Sciences, a [...]

Sanofi sur le point d'acquérir Protein Sciences

11/07/2017 - 07:00

Sanofi sur le point d'acquérir Protein Sciences - Cette acquisition permettra à Sanofi Pasteur d'enrichir son portefeuille d'un vaccin antigrippal recombinant - Paris, France - Le 11 juillet 2017 - Sanofi annonce [...]

uniQure Announces Updated, Long-Term Clinical Data from Ongoing Phase I/II Trial of AMT-060 In Patients with Severe Hemophilia B

10/07/2017 - 19:01

Clinical Benefit Maintained in All Patients, with FIX Activity Persisting At Up To 18 Months of Follow-Up Second-dose Cohort Demonstrates Dose Response Up to One Year, with 84% Reduction in Spontaneous Bleeds and All [...]

Ossur Hf : Transactions in relation to share buyback program

10/07/2017 - 18:00

Announcement from Össur hf. No. 48/2017 Reykjavík, 10 July 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]

Sanofi : Disclosure of trading in own shares

10/07/2017 - 18:00

Reporting EN This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Sanofi : Déclaration des transactions sur actions propres

10/07/2017 - 18:00

Reporting FR This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]